A detailed history of Nisa Investment Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 1,742,343 shares of PFE stock, worth $45 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
1,742,343
Previous 1,623,870 7.3%
Holding current value
$45 Million
Previous $45.4 Million 10.98%
% of portfolio
0.3%
Previous 0.29%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$27.7 - $31.39 $3.28 Million - $3.72 Million
118,473 Added 7.3%
1,742,343 $50.4 Million
Q2 2024

Jul 19, 2024

BUY
$25.26 - $29.6 $575,877 - $674,820
22,798 Added 1.42%
1,623,870 $45.4 Million
Q1 2024

May 01, 2024

SELL
$25.89 - $29.73 $2.16 Million - $2.48 Million
-83,283 Reduced 4.94%
1,601,072 $44.4 Million
Q4 2023

Jan 25, 2024

BUY
$26.13 - $33.94 $1.1 Million - $1.43 Million
42,035 Added 2.56%
1,684,355 $48.5 Million
Q3 2023

Nov 02, 2023

SELL
$32.09 - $37.51 $4.08 Million - $4.77 Million
-127,195 Reduced 7.19%
1,642,320 $54.5 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $1.35 Million - $1.56 Million
37,416 Added 2.16%
1,769,515 $64.9 Million
Q1 2023

May 02, 2023

SELL
$39.39 - $51.28 $1.17 Million - $1.52 Million
-29,597 Reduced 1.68%
1,732,099 $70.7 Million
Q4 2022

Feb 02, 2023

SELL
$41.75 - $54.5 $2.47 Million - $3.23 Million
-59,224 Reduced 3.25%
1,761,696 $90.3 Million
Q3 2022

Nov 07, 2022

BUY
$43.76 - $53.42 $1.54 Million - $1.88 Million
35,216 Added 1.97%
1,820,920 $79.8 Million
Q2 2022

Aug 03, 2022

BUY
$46.53 - $55.17 $906,543 - $1.07 Million
19,483 Added 1.1%
1,785,704 $93.6 Million
Q1 2022

Apr 29, 2022

SELL
$45.75 - $56.69 $2.72 Million - $3.37 Million
-59,505 Reduced 3.26%
1,766,221 $91.4 Million
Q4 2021

Feb 03, 2022

BUY
$41.32 - $61.25 $2.64 Million - $3.91 Million
63,892 Added 3.63%
1,825,726 $96.2 Million
Q3 2021

Oct 18, 2021

SELL
$39.25 - $50.42 $635,850 - $816,804
-16,200 Reduced 0.91%
1,761,834 $75.8 Million
Q2 2021

Aug 06, 2021

SELL
$35.91 - $40.68 $8.56 Million - $9.69 Million
-238,240 Reduced 11.82%
1,778,034 $69.6 Million
Q1 2021

Apr 26, 2021

SELL
$33.49 - $37.77 $5.41 Million - $6.1 Million
-161,600 Reduced 7.42%
2,016,274 $73.1 Million
Q4 2020

Jan 25, 2021

SELL
$33.47 - $42.56 $377,206 - $479,651
-11,270 Reduced 0.51%
2,177,874 $80.2 Million
Q3 2020

Oct 20, 2020

BUY
$31.75 - $37.25 $1.45 Million - $1.7 Million
45,530 Added 2.12%
2,189,144 $80.3 Million
Q2 2020

Jul 27, 2020

SELL
$30.12 - $36.54 $673,844 - $817,472
-22,372 Reduced 1.03%
2,143,614 $70.1 Million
Q1 2020

Apr 17, 2020

SELL
$27.03 - $38.62 $2 Million - $2.86 Million
-74,000 Reduced 3.3%
2,165,986 $70.7 Million
Q4 2019

Jan 17, 2020

SELL
$32.92 - $37.36 $2.09 Million - $2.37 Million
-63,475 Reduced 2.76%
2,239,986 $87.8 Million
Q3 2019

Oct 17, 2019

SELL
$32.49 - $42.13 $780,767 - $1.01 Million
-24,031 Reduced 1.03%
2,303,461 $82.8 Million
Q2 2019

Jul 12, 2019

SELL
$36.98 - $41.52 $2.4 Million - $2.7 Million
-64,980 Reduced 2.72%
2,327,492 $101 Million
Q1 2019

Apr 17, 2019

SELL
$37.5 - $41.2 $4.89 Million - $5.38 Million
-130,500 Reduced 5.17%
2,392,472 $102 Million
Q4 2018

Jan 17, 2019

BUY
$38.47 - $43.86 $2.04 Million - $2.32 Million
53,000 Added 2.15%
2,522,972 $110 Million
Q3 2018

Oct 16, 2018

BUY
$34.47 - $41.81 $2.02 Million - $2.45 Million
58,601 Added 2.43%
2,469,972 $109 Million
Q2 2018

Jul 19, 2018

BUY
$32.98 - $35.16 $2.65 Million - $2.83 Million
80,457 Added 3.45%
2,411,371 $87.5 Million
Q1 2018

Apr 10, 2018

SELL
$31.91 - $37.02 $2.31 Million - $2.68 Million
-72,400 Reduced 3.01%
2,330,914 $83.1 Million
Q4 2017

Jan 12, 2018

SELL
$33.26 - $35.29 $1.24 Million - $1.32 Million
-37,354 Reduced 1.53%
2,403,314 $87 Million
Q3 2017

Oct 13, 2017

BUY
$31.0 - $34.15 $75.7 Million - $83.3 Million
2,440,668
2,440,668 $87.1 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.